<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Cochrane McCracken | Activity</title>
	<link>https://www.catswannabecats.com/members/smellstamp6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/smellstamp6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Cochrane McCracken.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">283c1675f23e70cdbbc27a95404cb37b</guid>
				<title>Cochrane McCracken posted an update: The flow cytometry data indicated that a decreased number of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/10239/</link>
				<pubDate>Sun, 01 Jun 2025 00:06:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>The flow cytometry data indicated that a decreased number of CD4+ and CD8+ T cells in the peripheral blood of mice with EAE without affecting the number of T regulatory cells (CD4&nbsp;+&nbsp;CD25+ forkhead box protein 3+). Finally, it seems that maraviroc is well-tolerated, and targeting CCR5 could open up a new horizon in the treatment of MS.&hellip;<span class="activity-read-more" id="activity-read-more-10239"><a href="https://www.catswannabecats.com/activity/p/10239/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1b7526a2e0af649ade0f963c36f1095d</guid>
				<title>Cochrane McCracken became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8731/</link>
				<pubDate>Sat, 31 May 2025 21:35:59 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>